7C–D , the bone volume fraction and trabecular thickness showed an increasing trend in cyperenoic acid-treated group, but the difference did not reach statistical significance.
← all excerpts
Cyperenoic acid suppresses osteoclast differentiation and delays bone loss in a senile osteoporosis mouse model by inhibiting non-canonical NF-κB pathway.
1
—
—